A5043479332- Renal cell carcinoma treatment
- Urinary Bladder and Prostate Research
- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Renal and related cancers
- Prostate Cancer Treatment and Research
- Urological Disorders and Treatments
- Pelvic floor disorders treatments
- Pediatric Urology and Nephrology Studies
- Minimally Invasive Surgical Techniques
- Multiple and Secondary Primary Cancers
- Renal and Vascular Pathologies
- Kidney Stones and Urolithiasis Treatments
- Urinary and Genital Oncology Studies
- Ureteral procedures and complications
- Hormonal and reproductive studies
- Cancer Genomics and Diagnostics
- Radiopharmaceutical Chemistry and Applications
- Genital Health and Disease
- Urologic and reproductive health conditions
- Urinary Tract Infections Management
- Organ Donation and Transplantation
- Sexual function and dysfunction studies
- Pancreatic and Hepatic Oncology Research
- Adrenal and Paraganglionic Tumors
Villa Torri Hospital
2019-2025
University of Campania "Luigi Vanvitelli"
2024
Rush University
2024
Azienda Ospedaliera Universitaria Integrata Verona
2024
Policlinico Umberto I
2024
Rush University Medical Center
2024
National Cancer Institute
2024
Hesperia Hospital
2021-2024
Clinica Valle Giulia
2024
University of Chieti-Pescara
2019-2023
To analyze to what extent histologic subtype is of prognostic importance in renal cell carcinoma based on a large, international, multicenter experience.Four thousand sixty-three patients from eight international centers were included this retrospective study. Histologic (1997 International Union Against Cancer [UICC] criteria tumor response), age, sex, TNM stage, Fuhrman grade, size, Eastern Cooperative Oncology Goup performance status (ECOG PS), and overall survival determined all cases....
We tested the hypothesis that prediction of renal cancer-specific survival can be improved if traditional predictor variables are used within a prognostic nomogram.Two cohorts patients treated with either radical or partial nephrectomy for cortical tumors were used: one (n = 2,530) nomogram development and internal validation (200 bootstrap resamples), second 1,422) external validation. Cox proportional hazards regression analyses modeled 2002 TNM stages, tumor size, Fuhrman grade,...
You have accessJournal of UrologyTuesday, May 11, 2004, 1:00 - 3:00 pm1 Apr 20041653: Safety and Efficacy Partial Nephrectomy for all T1 Tumors Based on an International Multicenter Experience Jean-Jacques Patard, Oleg Shvarts, Allan J. Pantuck, Vincenzo Ficarra, Hyung L. Kim, Luca Cindolo, Ken Han, Alexandre De La Taille, Jacques Tostain, Walter Artibani, ClementClaude Abbou, Bernard Lobel, Dominique Chopin, Franfois Guille, Robert A. Figlin, Peter Mulders, Arie S. Belldegrun...
To evaluate ability of the University California Los Angeles Integrated Staging System (UISS) to stratify patients with localized and metastatic renal cell carcinoma (RCC) into risk groups in an international multicenter study.4,202 from eight academic centers were classified according UISS, which combines TNM stage, Fuhrman grade, Eastern Cooperative Oncology Group performance status. Distribution UISS categories was assessed overall population each center.The stratified both RCC three...
The objective of the current study was to compare, in a large multicenter study, discriminating accuracy four prognostic models developed predict survival patients undergoing nephrectomy for nonmetastatic renal cell carcinoma (RCC).A total 2404 records from 6 European centers were retrospectively reviewed. For each patient, scores calculated according models: Kattan model, University California at Los Angeles integrated staging system (UISS) Yaycioglu and Cindolo model. Survival curves...
To compare the functional outcomes of on- vs off-clamp robot-assisted partial nephrectomy (RAPN) within a randomized controlled trial (RCT).The CLOCK study (CLamp Off Clamp Kidney during robotic nephrectomy; NCT02287987) is multicentre RCT including patients with normal baseline function, two kidneys and masses RENAL scores ≤ 10. Pre- postoperative renal scintigraphy was prescribed. Renal defatting hilum isolation were required in both arms; on-clamp arm, ischaemia imposed until completion...
The Fuhrman grading system is an established predictor of survival in patients with renal cell carcinoma (RCC). predictive accuracy various schemes was tested the intent improving prediction RCC-specific (RCC-SS).The analyses targeted 5453 from 14 institutions. Univariable, multivariable, and addressed RCC-SS. statistical significance gain quantified Mantel-Haenszel test.The median follow-up time 4.5 years. In both univariable multivariable analyses, grade achieved independent status...
Authors from Naples, Paris and Rennes describe their efforts to develop a model for the preoperative prediction of outcome non‐metastatic renal cancer. It is valuable both urologist patient such model, particularly so on criteria. The results study are interesting, leading possibly helpful findings. In another article, authors Iceland estimated risk developing prostate other cancer among relatives men that country diagnosed with They found family history factor cancer, potentially higher...
We validate the prognostic value of a symptom based classification (S classification) in multi-institutional study.A total 2,242 patients from 5 European centers were included this study. Based on symptoms at diagnosis, stratified into 3 groups S1-asymptomatic tumors, S2-tumors with local and S3-tumors systemic symptoms. Variables such as age, gender, tumor size, TNM stage, Fuhrman grade, Eastern Cooperative Oncology Group (ECOG) performance status, perinephric fat, renal vein adrenal...
Objectives To assess the prognostic impact of time to recurrence ( TTR ) on cancer‐specific survival CSS after in patients with renal cell carcinoma RCC undergoing radical nephrectomy or nephron‐sparing surgery. analyse differences clinical and histopathological criteria between early late recurrence. Patients Methods Of 13 107 from an international multicentre database, 1712 developed follow‐up FU ), at a median (interquartile range) 50.1 (25–106) months. In all, 1402 had ≤5 years (Group A)...